“ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW”. Proceedings of the Global Public Health Conference, vol. 9, no. 01, June 2026, pp. 14-30, https://doi.org/10.17501/26138417.2026.9102.